|
SCYL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.770400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.402400E-01 |
| Normal-vs-Stage2 |
9.257600E-01 |
| Normal-vs-Stage3 |
1.641010E-01 |
| Normal-vs-Stage4 |
1.956990E-01 |
| Stage1-vs-Stage2 |
9.605200E-01 |
| Stage1-vs-Stage3 |
1.264430E-01 |
| Stage1-vs-Stage4 |
2.377600E-01 |
| Stage2-vs-Stage3 |
2.558400E-01 |
| Stage2-vs-Stage4 |
3.091200E-01 |
| Stage3-vs-Stage4 |
9.731000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.504400E-01 |
| Normal-vs-AfricanAmerican |
8.521600E-01 |
| Normal-vs-Asian |
4.399200E-01 |
| Caucasian-vs-AfricanAmerican |
5.483400E-01 |
| Caucasian-vs-Asian |
7.971400E-01 |
| AfricanAmerican-vs-Asian |
4.623600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.597200E-01 |
| Normal-vs-Female |
5.787400E-01 |
| Male-vs-Female |
5.824200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.648600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.084800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.102800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.874400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.004350E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.667600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.765000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.644000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.983200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.988000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.248200E-01 |
| Classical-VS-Follicular |
3.977400E-01 |
| Classical-VS-Other |
1.973390E-01 |
| Classical-VS-Normal |
9.788000E-01 |
| Tall-VS-Follicular |
6.353800E-01 |
| Tall-VS-Other |
4.913600E-01 |
| Tall-VS-Normal |
2.311600E-01 |
| Follicular-VS-Other |
4.165800E-01 |
| Follicular-VS-Normal |
4.763600E-01 |
| Other-VS-Normal |
1.251190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.766000E-01 |
| Normal-vs-N1 |
2.674600E-01 |
| N0-vs-N1 |
7.181600E-01 |
|
|
